glp 1 france Arkopharma GLP-1 Slimming expert 270 g Inside Europe's AI-Fuelled GLP-1 Scam

Description

W.de MelloL

All views are my own As we get closer to first patient first dose on our ENDOCAN-1 endometriosis clinical trial, I have been thinking a lot about the symptom burden of this shocking condition

Since the FDA approved Ozempic in 2017, the drugs manufacturer, Novo Nordisk, has not included warnings that the medication can cause gastroparesis in its prescription information

Pemvidutide and survodutide are both GLP-1/glucagon dual agonists being developed for obesity and MASH, but survodutide is further ahead in clinical development with more advanced Phase 3 programs, higher-tier regulatory designations (Breakthrough Therapy vs Fast Track), and greater weight loss in Phase 2 (18.7% vs 15.6%)